Perspectives

The recent ruling (21 November 2018) of the European Court of Justice puts an end to the dispute over the off-label use of bevacizumab for age-related macular degeneration.

Focus on

Indications for medical useTetrahydrocannabinol (THC) and cannabidiol (CBD) are the main active substances of cannabis sativa and among the pharmacological targets have both cannabinoid receptors (CB1 and CB2), the peptide receptor related to the calcitonin gene, the ligand dependent ion channels...

Columns

Phytovigilance & Supplements
IntroductionSince 2002, the Italian National Institute of Health (ISS) has coordinated the national phyto-vigilance system.1 This system is based on the collection and evaluation of spontaneous reports of suspected adverse reactions that have occurred after taking food supplements, vitamins,...